Pacira Pharmaceuticals(PCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PCRX Pacira Pharmaceuticals

休市中 11-22 16:00:00 EST

17.55

+0.17

+0.98%

盘后17.55

+0.000.00%

16:23 EST

最高17.78	最低17.24	成交量49.52万
今开17.41	昨收17.38	日振幅3.11%
总市值8.10亿	流通市值8.02亿	总股本4,617万
成交额871.34万	换手率1.08%	流通股本4,567万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PCRX","market":"US","secType":"STK","nameCN":"Pacira Pharmaceuticals","latestPrice":17.55,"timestamp":1732309200000,"preClose":17.38,"halted":0,"volume":495169,"hourTrading":{"tag":"盘后","latestPrice":17.55,"preClose":17.55,"latestTime":"16:23 EST","volume":16062,"amount":281887.15,"timestamp":1732310619580},"delay":0,"floatShares":45673881,"shares":46173240,"eps":-1.959188,"marketStatus":"休市中","marketStatusCode":7,"change":0.17,"latestTime":"11-22 16:00:00 EST","open":17.41,"high":17.78,"low":17.24,"amount":8713358.663553,"amplitude":0.03107,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.959188,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1296709200000,"adjPreClose":17.38,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":14.31,"preClose":17.38,"latestTime":"06:55 EST","volume":2,"amount":27.69,"timestamp":1732276523258},"postHourTrading":{"tag":"盘后","latestPrice":17.55,"preClose":17.55,"latestTime":"16:23 EST","volume":16062,"amount":281887.15,"timestamp":1732310619580},"volumeRatio":0.7770547965704202,"impliedVol":0.6015,"impliedVolPercentile":0.4643},"requestUrl":"/m/hq/s/PCRX","defaultTab":"news","newsList":[{"id":"2483306712","title":"Pacira Biosciences, Inc.2024财年第三财季实现净利润-1.43亿美元，同比减少1416.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483306712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483306712?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686419,"startTime":"0","endTime":"0","summary":"11月16日，Pacira Biosciences, Inc.公布财报，公告显示公司2024财年第三财季净利润为-1.43亿美元，同比减少1416.76%；其中营业收入为1.69亿美元，同比增加3.05%，每股基本收益为-3.11美元。从资产负债表来看，Pacira Biosciences, Inc.总负债7.72亿美元，其中短期债务2.11亿美元，资产负债比为1.98，流动比率为2.26。机构评级：截至2024年11月16日，当前有8家机构对Pacira Biosciences, Inc.目标价做出预测，其中目标均价为18.00美元，其中最低目标价为8.00美元，最高目标价为39.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000029a23b87ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000029a23b87ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCRX"],"gpt_icon":0},{"id":"2483051125","title":"Pacira Biosciences, Inc.盘中异动 临近收盘快速下挫5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483051125","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483051125?lang=zh_cn&edition=full","pubTime":"2024-11-13 04:38","pubTimestamp":1731443922,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日04时38分，Pacira Biosciences, Inc.股票出现异动，股价急速下挫5.14%。Pacira Biosciences, Inc.股票所在的制药行业中，整体跌幅为1.32%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111304384398e422bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111304384398e422bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BFRI","BK4007","PCRX"],"gpt_icon":0},{"id":"2481559184","title":"Pacira Biosciences Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2481559184","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481559184?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:09","pubTimestamp":1730992186,"startTime":"0","endTime":"0","summary":"Pacira Biosciences Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要Pacira Biosciences Inc PCRX.OQ公布的截至9月30日的季度调整后每股收益为79美分，高于去年同期的每股收益72美分。华尔街预期为每股收益 58 美分至 93 美分。Pacira Biosciences 公司公布的本季度每股收益为亏损 3.11 美元。Pacira Biosciences Inc 本季度股价上涨了 17.4%，今年迄今为止亏损了 47.6%。华尔街对 Pacira Biosciences Inc 的 12 个月目标价中位数为 18.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nL4S3ME24P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PCRX"],"gpt_icon":0},{"id":"2481963922","title":"Pacira Biosciences, Inc.盘中异动 下午盘急速拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481963922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481963922?lang=zh_cn&edition=full","pubTime":"2024-11-06 02:17","pubTimestamp":1730830675,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日02时17分，Pacira Biosciences, Inc.股票出现波动，股价大幅拉升5.11%。Pacira Biosciences, Inc.股票所在的制药行业中，整体跌幅为0.31%。其相关个股中，Painreform Ltd.、Citius Oncology, Inc.、Quantum Biopharma Ltd.涨幅较大，Evoke Pharma, Inc.、Biofrontera Inc.、Shuttle Pharmaceuticals Holdings, Inc.较为活跃，换手率分别为12.87%、9.26%、5.84%，振幅较大的相关个股有Biofrontera Inc C/Wts 27/10/2026 、Shuttle Pharmaceuticals Holdings, Inc.、Aytu Biopharma, Inc.，振幅分别为33.75%、22.50%、18.85%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106021755a21929a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106021755a21929a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCRX","BFRI"],"gpt_icon":0},{"id":"2481502355","title":"Pacira Biosciences Inc    预计每股收益 70 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481502355","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481502355?lang=zh_cn&edition=full","pubTime":"2024-11-05 05:35","pubTimestamp":1730756108,"startTime":"0","endTime":"0","summary":"   * Pacira Biosciences Inc    将于11月6日公布截至2024年9月30日的季度财报，预计该公司的季度收入将有所增长。* LSEG 分析师对 Pacira Biosciences Inc 的平均预期为每股收益 70 美分。* 目前分析师对该公司股票的平均评级为 \"持有\"，建议的细分为 3 个 \"强烈买入 \"或 \"买入\"，4 个 \"持有\"，2 个 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Pacira Biosciences Inc 的 12 个月目标价中位数为 18.00 美元，高于其上次收盘价 16.57 美元。11月4日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Pacira Biosciences Inc    预计每股收益 70 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCRX"],"gpt_icon":0},{"id":"2479788903","title":"Pacira Biosciences Inc    预计每股收益 70 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2479788903","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479788903?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:30","pubTimestamp":1730295002,"startTime":"0","endTime":"0","summary":"   * Pacira Biosciences Inc    预计在11月1日公布截至2024年9月30日的业绩时，季度收入将有所增长(预计)    * 根据LSEG的数据，9位分析师的平均预期显示，这家总部位于佛罗里达州坦帕市的公司的营收将从去年同期的1.6393亿美元增至1.69672亿美元，增幅为3.5%。* LSEG 分析师对 Pacira Biosciences Inc 的平均预期为每股收益 70 美分。* 华尔街对 Pacira Biosciences Inc 的 12 个月目标价中位数为 18.00 美元，高于其最新收盘价 17.18 美元。10月30日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Pacira Biosciences Inc    预计每股收益 70 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCRX"],"gpt_icon":0},{"id":"2474046583","title":"Pacira Biosciences, Inc.盘中异动 下午盘股价大涨5.09%报16.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474046583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474046583?lang=zh_cn&edition=full","pubTime":"2024-10-12 02:49","pubTimestamp":1728672550,"startTime":"0","endTime":"0","summary":"北京时间2024年10月12日02时49分，Pacira Biosciences, Inc.股票出现波动，股价急速拉升5.09%。截至发稿，该股报16.30美元/股，成交量43.4073万股，换手率0.94%，振幅4.99%。Pacira Biosciences, Inc.股票所在的制药行业中，整体涨幅为1.35%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241012024910ab697af0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241012024910ab697af0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","UPC","PCRX"],"gpt_icon":0},{"id":"2473102451","title":"Pacira Biosciences, Inc.盘中异动 快速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473102451","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473102451?lang=zh_cn&edition=full","pubTime":"2024-10-07 23:12","pubTimestamp":1728313926,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日23时12分，Pacira Biosciences, Inc.股票出现异动，股价急速下挫5.03%。Pacira Biosciences, Inc.股票所在的制药行业中，整体涨幅为0.59%。其相关个股中，Cyclo Therapeutics Inc C/Wts 11/12/2025、Sunshine Biopharma Inc C/Wts 、Flora Growth Corp.涨幅较大，Biofrontera Inc.、Sunshine Biopharma Inc.、Quantum Biopharma Ltd.较为活跃，换手率分别为37.47%、4.25%、3.79%，振幅较大的相关个股有Cyclo Therapeutics Inc C/Wts 11/12/2025、Scilex Holding Company、Biofrontera Inc.，振幅分别为74.87%、18.50%、15.63%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007231207ab681db4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007231207ab681db4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BFRI","PCRX","BK4007"],"gpt_icon":0},{"id":"2460032572","title":"Pacira Biosciences, Inc.盘中异动 早盘快速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460032572","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460032572?lang=zh_cn&edition=full","pubTime":"2024-08-19 21:51","pubTimestamp":1724075514,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日21时51分，Pacira Biosciences, Inc.股票出现异动，股价急速上涨5.02%。Pacira Biosciences, Inc.股票所在的制药行业中，整体涨幅为0.14%。其相关个股中，Scilex Holding Company C/Wts 10/11/2027 、Intercure Ltd.、Biofrontera Inc.涨幅较大，Redhill Biopharma Ltd、Quantum Biopharma Ltd.、Sunshine Biopharma Inc.较为活跃，换手率分别为54.03%、9.16%、4.77%，振幅较大的相关个股有Redhill Biopharma Ltd、Emergent Biosolutions, Inc.、Siga Technologies Inc.，振幅分别为14.82%、14.52%、10.58%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921515497199242&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921515497199242&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCRX","BK4007"],"gpt_icon":0},{"id":"2459476478","title":"Pacira Biosciences, Inc.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459476478","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459476478?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:55","pubTimestamp":1723730153,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时55分，Pacira Biosciences, Inc.股票出现波动，股价快速拉升5.05%。Pacira Biosciences, Inc.股票所在的制药行业中，整体跌幅为0.10%。其相关个股中，Scilex Holding Company C/Wts 10/11/2027 、Biofrontera Inc.、Rockwell Medical, Inc.涨幅较大，Siga Technologies Inc.、Sunshine Biopharma Inc.、Emergent Biosolutions, Inc.较为活跃，换手率分别为6.91%、3.17%、1.53%，振幅较大的相关个股有Scilex Holding Company C/Wts 10/11/2027 、Biofrontera Inc.、Rockwell Medical, Inc.，振幅分别为39.75%、12.28%、10.59%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815215553a1d47216&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815215553a1d47216&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BFRI","BK4007","PCRX"],"gpt_icon":0},{"id":"2458473984","title":"Pacira Biosciences, Inc.盘中异动 早盘股价大涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458473984","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458473984?lang=zh_cn&edition=full","pubTime":"2024-08-12 22:42","pubTimestamp":1723473720,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日22时42分，Pacira Biosciences, Inc.股票出现波动，股价急速拉升5.56%。Pacira Biosciences, Inc.股票所在的制药行业中，整体涨幅为0.02%。其相关个股中，Akebia Therapeutics, Inc.、Biofrontera Inc.、Siga Technologies Inc.涨幅较大，Fsd Pharma Inc.、Mira Pharmaceuticals, Inc.、Sunshine Biopharma Inc.较为活跃，换手率分别为186.72%、22.72%、10.92%，振幅较大的相关个股有脑再生科技、Fsd Pharma Inc.、Tilray Brands, Inc.，振幅分别为30.17%、29.90%、18.44%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408122242009420008c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408122242009420008c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCRX"],"gpt_icon":0},{"id":"2458749620","title":"美国研究综述-Airbnb、通用美元、沃尔玛","url":"https://stock-news.laohu8.com/highlight/detail?id=2458749620","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458749620?lang=zh_cn&edition=full","pubTime":"2024-08-12 15:40","pubTimestamp":1723448430,"startTime":"0","endTime":"0","summary":"    路透8月12日 - 华尔街证券分析师周一调整了对多家美国上市公司的评级和目标价，其中包括 Airbnb、Dollar General 和沃尔玛。要闻             * Airbnb Inc   ：杰富瑞将目标价从 150 美元下调至 125 美元              * Dollar General Corp   ：杰富瑞将目标价从160美元下调至145美元             * Hilton Grand Vacations Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Pacira Biosciences Inc   ：摩根大通将目标价从45美元下调至10美元              * Pacira Biosciences Inc   ：Piper Sandler将目标价从42美元下调至11美元             * Pacira Biosciences Inc   ：Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4173","GHLD","ZD","BURL","PCRX","RDNT","ITOS","DLTR","EWTX","ARDT","GSHD","SKY","DG","LU2361045086.USD","IE0034390439.USD","CBUS","BK4175","EXPE","GCMG","OKE","RDFN","CCOI","BJ","FMC","LU2361044949.HKD","HGV","LU0211327993.USD","ABNB","LU1066051225.USD","BK4535","PX","OPAD","STEP","NNI","ROK","SWIM","BTAI","WMT","FTDR","BWIN","CARG","HLMN","HBI","LU1069347547.HKD","NTLA","LU2361044865.SGD","CC","HSIC","LEGH"],"gpt_icon":1},{"id":"1180037935","title":"异动解读 | Pacira Pharmaceuticals盘后大涨6.84% 机构看好公司前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1180037935","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180037935?lang=zh_cn&edition=full","pubTime":"2024-08-10 04:38","pubTimestamp":1723235906,"startTime":"0","endTime":"0","summary":"Pacira Pharmaceuticals公司股价在盘后交易中大涨6.84%,引发市场关注。分析人士认为,这可能与机构对该公司前景的看好有关。根据最新财报数据,Pacira Pharmaceuticals实现营业收入1.78亿美元,净利润1889万美元,每股收益0.41美元,毛利1.19亿美元。值得注意的是,在参与评级的9家机构中,有89%的机构给予该股买入评级,只有11%的机构给予持有评级,没有任何卖出评级。这表明机构对Pacira Pharmaceuticals的长期发展前景持乐观态度,有望为股价带来支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCRX"],"gpt_icon":0},{"id":"2458951965","title":"Pacira Biosciences, Inc.盘中异动 股价大涨5.41%报23.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458951965","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458951965?lang=zh_cn&edition=full","pubTime":"2024-08-10 00:37","pubTimestamp":1723221464,"startTime":"0","endTime":"0","summary":"北京时间2024年08月10日00时37分，Pacira Biosciences, Inc.股票出现波动，股价快速上涨5.41%。Pacira Biosciences, Inc.股票所在的制药行业中，整体涨幅为3.04%。其相关个股中，Fsd Pharma Inc.、Sunshine Biopharma Inc C/Wts 、Alvotech C/Wts 涨幅较大，Fsd Pharma Inc.、Sunshine Biopharma Inc.、Biofrontera Inc.较为活跃，换手率分别为1877.67%、9.88%、7.06%，振幅较大的相关个股有Fsd Pharma Inc.、Sunshine Biopharma Inc C/Wts 、Sunshine Biopharma Inc.，振幅分别为230.91%、62.89%、30.62%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810003745af96d6eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810003745af96d6eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCRX"],"gpt_icon":0},{"id":"1148476636","title":"异动解读 | Pacira Pharmaceuticals股价大涨5.15% 机构看好公司前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1148476636","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148476636?lang=zh_cn&edition=full","pubTime":"2024-08-06 22:52","pubTimestamp":1722955961,"startTime":"0","endTime":"0","summary":"Pacira Pharmaceuticals公司今日股价盘中大涨5.15%,报收21.23美元/股。这一涨幅引发了市场的广泛关注。分析人士认为,Pacira Pharmaceuticals股价大涨或与机构对该公司前景看好有关。最新数据显示,在参与评级的9家机构中,有89%的机构给予该股买入评级,看好公司未来发展前景。Pacira Pharmaceuticals是一家非阿片类疼痛管理和再生健康解决方案提供商,旗下产品包括EXPAREL、ZILRETTA和Iovera等。公司最新财报显示,营业收入达1.78亿美元,净利润1889万美元,每股收益0.41美元,业绩表现良好。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCRX"],"gpt_icon":0},{"id":"2457023761","title":"Pacira Biosciences, Inc.盘中异动 股价大涨5.19%报21.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457023761","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457023761?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:51","pubTimestamp":1722952274,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日21时51分，Pacira Biosciences, Inc.股票出现异动，股价快速上涨5.19%。截至发稿，该股报21.23美元/股，成交量5.7016万股，换手率0.12%，振幅5.57%。Pacira Biosciences, Inc.股票所在的制药行业中，整体涨幅为0.35%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806215115968245fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806215115968245fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCRX"],"gpt_icon":0},{"id":"2457700773","title":"Pacira Biosciences, Inc.盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457700773","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457700773?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:39","pubTimestamp":1722865197,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时39分，Pacira Biosciences, Inc.股票出现波动，股价急速跳水5.08%。Pacira Biosciences, Inc.股票所在的制药行业中，整体跌幅为2.80%。其相关个股中，Incannex Healthcare Inc.、Scilex Holding Company C/Wts 10/11/2027 、Cbdmd, Inc.涨幅较大，苏轩堂、Akanda Corp.、Painreform Ltd.较为活跃，换手率分别为12.68%、11.23%、10.21%，振幅较大的相关个股有Durect Corporation、Akanda Corp.、Painreform Ltd.，振幅分别为15.79%、12.50%、10.59%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213957af95fad1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213957af95fad1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCRX"],"gpt_icon":0},{"id":"2456221688","title":"Pacira Biosciences, Inc.2024财年第二财季实现净利润18.89百万美元，同比减少26.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456221688","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456221688?lang=zh_cn&edition=full","pubTime":"2024-08-04 00:22","pubTimestamp":1722702129,"startTime":"0","endTime":"0","summary":"8月4日，Pacira Biosciences, Inc.公布财报，公告显示公司2024财年第二财季净利润为18.89百万美元，同比减少26.67%；其中营业收入为1.78亿美元，同比增加5.33%，每股基本收益为0.41美元。从资产负债表来看，Pacira Biosciences, Inc.总负债7.68亿美元，其中短期债务9.15百万美元，资产负债比为2.15，流动比率为0.07。机构评级：截至2024年8月4日，当前有9家机构对Pacira Biosciences, Inc.目标价做出预测，其中目标均价为38.44美元，其中最低目标价为25.00美元，最高目标价为57.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240804002213957ab3ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240804002213957ab3ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCRX"],"gpt_icon":0},{"id":"1194594603","title":"异动解读 | Pacira Pharmaceuticals股价大涨13.89% 市值增加近2亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1194594603","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194594603?lang=zh_cn&edition=full","pubTime":"2024-07-31 21:46","pubTimestamp":1722433577,"startTime":"0","endTime":"0","summary":"Pacira Pharmaceuticals公司今日股价大涨13.89%,引发市场广泛关注。该公司是一家非阿片类疼痛管理和再生健康解决方案提供商,主要产品包括EXPAREL、ZILRETTA和Iovera等。分析人士认为,导致该公司股价大涨的主要原因可能与其最新财报数据有关。财报显示,Pacira Pharmaceuticals实现营业收入1.67亿美元,净利润898万美元,每股收益0.19美元,毛利1.05亿美元,市盈率为16.05倍。此外,机构评级也为该股价上涨增添了动力。这反映出机构对Pacira Pharmaceuticals的发展前景持乐观态度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCRX"],"gpt_icon":0},{"id":"2455315491","title":"Pacira Biosciences, Inc.股价飙升10.08% 市值涨1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455315491","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455315491?lang=zh_cn&edition=full","pubTime":"2024-07-31 21:31","pubTimestamp":1722432667,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日21时31分，Pacira Biosciences, Inc.股票出现异动，股价急速拉升10.08%。Pacira Biosciences, Inc.股票所在的制药行业中，整体跌幅为0.06%。其相关个股中，Pacira Biosciences, Inc.、Incannex Healthcare Inc.、Cbdmd, Inc.涨幅较大，Mira Pharmaceuticals, Inc.、苏轩堂、Sonoma Pharmaceuticals, Inc.较为活跃，换手率分别为1.15%、1.00%、0.72%，振幅较大的相关个股有Sonoma Pharmaceuticals, Inc.、Lantheus Holdings, Inc.、Pacira Biosciences, Inc.，振幅分别为5.35%、4.55%、3.48%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407312131079f022d67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407312131079f022d67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCRX","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pacira.com","stockEarnings":[{"period":"1week","weight":0.0572},{"period":"1month","weight":0.0098},{"period":"3month","weight":0.2368},{"period":"6month","weight":-0.4089},{"period":"1year","weight":-0.3425},{"period":"ytd","weight":-0.4798}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Pacira BioSciences, Inc.是一家专业制药公司，专注于医药产品的开发、商业化和制造，该公司专有的DepoFoam药物传递技术，主要用于医院和门诊手术中心。2011年10月28日，美国食品和药物管理局（ FDA）批准该公司的新药申请，即公司的主导产品EXPAREL，这是一种脂质体注射布比卡因，酰胺类局麻药表示为渗透进入手术部位，术后镇痛长达72小时。该公司认为EXPAREL解决了长效非阿片类镇痛手术后，一个显著的医疗需要，从而简化手术后疼痛控制和减少阿片类药物用量，从而提高患者的治疗效果，提高医院经济效益。该公司开发的内部销售团队完全致力于EXPAREL商业化，该公司已于2012年4月把产品推出市场。此外，继2013年10月1日生效的一个实验方案，该公司任命CrossLink BioScience, LLC（CrossLink），为一个为期五年的独家第三方分销商推广和销售EXPAREL在美国骨科和脊柱外科手术成立一个团队，如果某些地区和账户如有变更，需要经过双方同意才能调整。 该公司成立于2006年12月，并自2007年3月已开展关于EXPAREL业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.615385,"avgChangeRate":0.042499},{"month":2,"riseRate":0.692308,"avgChangeRate":0.029842},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.007802},{"month":4,"riseRate":0.571429,"avgChangeRate":0.037069},{"month":5,"riseRate":0.571429,"avgChangeRate":0.025955},{"month":6,"riseRate":0.428571,"avgChangeRate":0.019619},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.025732},{"month":8,"riseRate":0.5,"avgChangeRate":-0.000921},{"month":9,"riseRate":0.357143,"avgChangeRate":-0.009931},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.017543},{"month":11,"riseRate":0.714286,"avgChangeRate":0.066155},{"month":12,"riseRate":0.538462,"avgChangeRate":0.032185}],"exchange":"NASDAQ","name":"Pacira Pharmaceuticals","nameEN":"Pacira Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pacira Pharmaceuticals(PCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Pacira Pharmaceuticals(PCRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Pacira Pharmaceuticals,PCRX,Pacira Pharmaceuticals股票,Pacira Pharmaceuticals股票老虎,Pacira Pharmaceuticals股票老虎国际,Pacira Pharmaceuticals行情,Pacira Pharmaceuticals股票行情,Pacira Pharmaceuticals股价,Pacira Pharmaceuticals股市,Pacira Pharmaceuticals股票价格,Pacira Pharmaceuticals股票交易,Pacira Pharmaceuticals股票购买,Pacira Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pacira Pharmaceuticals(PCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Pacira Pharmaceuticals(PCRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}